The chemokine receptor CXCR4 modulates endothelial progenitor cell migration, homing, and differentiation, and plays a key role in cardiovascular regeneration. Here we examined the effect of ex vivo acidic preconditioning (AP) on CXCR4 expression and on the regenerative potential of mouse bone marrow (BM) ckit + cells.
Introduction
Cell therapy is a promising strategy for the treatment of a variety of cardiovascular ailments, including myocardial infarction and limb ischaemia. However, bone marrow (BM) cells from elderly patients and individuals with cardiovascular risk factors, including diabetes, 1,2 hypercholesterolaemia, 3 hypertension, 3 and smoking, 4 exhibit limited therapeutic potential. Therefore, there is a strong clinical need to develop cell enhancement strategies to improve the clinical benefit of BM cell transplantation. BM cells have been evaluated ex vivo, prior to being transplanted, and it has been shown that stromal cell-derived factor 1 (SDF-1) can direct cell migration, 5 -7 gauge BM cell quality, and predict therapeutic efficacy following transplantation. This is in agreement with the well-known role of SDF-1 and its receptor, CXCR4, in tissue repair. In response to ischaemia, SDF-1 is upregulated and acts as a potent chemoattractant to recruit circulating and resident CXCR4 + progenitor cells to the injury site. 5,7 -9 Further, ex vivo exposure to nitric oxide (NO) donors can increase BM cells regenerative properties 10 and this positive effect has been related to enhanced CXCR4 expression. 7,11 -13 Preconditioning with brief episodes of acidosis is known to limit ischaemia/reperfusion injury in the heart, 14,15 lung, 16, 17 and endothelium 18, 19 ; the mechanism(s) for this response have not been elucidated but may involve activation of prosurvival kinases Akt and ERK, and the overexpression of antiapoptotic protein Bcl-XL. However, it is still unknown whether acidic preconditioning (AP) ex vivo enhances BM cells therapeutic potential. We have previously shown that acidosis modulates CXCR4 expression and that this effect is cell-type specific; endothelial cells kept at pH 7.0 exhibit a decrease in CXCR4 expression, whereas in other cell types CXCR4 levels are unchanged. 20 Furthermore, Froyland et al. 21 demonstrated pH-dependent up-regulation of CXCR4 mRNA in NT2-N neurons during hypoxia/reoxygenation. The aim of the present work was to investigate the effect of AP on SDF-1/CXCR4 expression, on SDF-1/CXCR4-directed BM cell function in vitro, and regenerative potential in a mouse model of hindlimb ischaemia. We utilized BM ckit + cells because transplantation of these cells in the infarcted heart leads to myocardial and vascular regeneration, 22 therefore they represent an attractive population to develop cell therapy enhancement strategies.
Methods
For a detailed description of all methods, see Supplementary material online.
Animals
Swiss CD1 male mice, 4 -8-week-old, were used for ckit + cell iso- 
Cell isolation, culture, and treatments
See Supplementary material online, Methods.
Acidification protocol
Cells were seeded in 48 multi-well dishes (5 × 10 5 cells/well) and cultured in Stem Span serum-free medium (Stem Cell Technologies) containing the following recombinant human cytokines: 100 ng/mL stem cell factor, 20 ng/mL IL-3, 20 ng/mL IL-6, and 100 ng/mL Flt-3 ligand (R&D Systems). Immediately after seeding multi-well dishes were placed in airtight modular incubator chambers (Forma Scientific Inc) and infused for 20 min, with either 5%CO 2 /95% air or 20%CO 2 /80% air to achieve a buffer pH of 7.4 or 7.0, respectively, as previously described. 23 After gas mixture, infusion chambers were sealed and placed at 378C for the duration of the experiments, i.e. 24 h or longer, as indicated. After acidification, the dishes were removed from the incubator chambers and returned to 5%CO 2 /95% air to achieve a buffer pH of 7.4. Thereafter, the different assays were performed as described.
Analysis of proliferation and cell death Adhesion assay ckit + cell adhesion was analysed onto fibronectin-coated dishes and onto a monolayer of human umbilical vein endothelial cells (HUVECs). Assays were carried out in EBM-2 medium (Lonza).
Migration assay
Both SDF-1 (100 ng/mL, R&D Systems) directed chemotaxis and transendothelial migration across a HUVEC monolayer were evaluated as previously described. 24 
Differentiation assay
Cell differentiation assays were carried out in M199 medium (Sigma-Aldrich) supplemented with 20% FCS or 2% FCS + SDF-1 (100 ng/mL).
mRNA extraction and qRT-PCR 
Flow cytometry
Purity of each cell preparation, i.e. ckit + cell number, as well as the expression of CD34, Sca-1, Flk1/KDR, and CXCR4 by these cells, was assessed by FACS.
Nitric oxide production
Nitric oxide production was evaluated by 4,5-Diaminofluorescein (DAF-2 DA) (Alexis) added to the complete medium for 6 h and then analysed by FACS.
In vivo procedures and immunohistochemistry
Statistical analysis
Variables were analysed by two-side Student's t-test and two-way ANOVA. A value of P ≤ 0.05 was deemed statistically significant. Mean values are indicated + SEM. The GraphPad Prism software (version 5.00 for Windows, GraphPad Software, San Diego, CA, USA) was used for computer analysis.
Results
Effect of acidification on ckit 1 cell proliferation, death, and endothelial differentiation ckit + cells were isolated from mice and cultured in growth medium, either at pH 7.4 or 7.0 for 5 days. In order to characterize AP as an ex vivo strategy to enhance BM cells regenerative properties, the effect of prolonged acidosis was first analysed. Acidification markedly inhibited the progressive increase in cell number observed under control conditions ( Figure 1A) , without a significant effect on cell cycle (see Supplementary material online, Figure S1 ). The percentage of ckit + cells was .90% after isolation, decreased to 85% after 24 h and to 35% after 5 days in culture; interestingly, there was no effect of acidification on the percentage of cells expressing ckit, CD34, Sca-1, and KDR (see Supplementary material online, Figure S2 ). Additional experiments examined the effect of acidosis on cell death. By PI-staining and FACS analysis, acidification was found to enhance cell death both at 24 and 48 h ( Figure 1B ) and increase the number of caspase-3-positive cells at 48 h ( Figure 1C ); in contrast, it was found no significant increase in the number of caspase-9-positive cells (see Supplementary material online, Figure S3 ). Enhanced cell death at pH 7.0 may explain the apparent discrepancy between acidification ability to inhibit the progressive increase in cell number and the absence of an effect on cell cycle. Finally, the effect of acidification on ckit + cell differentiation toward the endothelial lineage was examined. ckit + cells were seeded onto fibronectin-coated dishes either at pH 7.4 or pH 7.0 in the presence of 20% FCS for 4 or 7 days. At both time points, a marked decrease in DiI-Ac-LDL positive cells was found at pH 7.0 vs. 7.4 ( Figure 1D ).
Effect of acidic preconditioning on ckit 1 cell proliferation and adhesion
The decrease in ckit + cell functions after prolonged exposure to pH 7.0 prompted us to examine the effect of AP for 24 h on cell proliferation and adhesion at different time points after returning to pH 7.4. AP cells proliferated at a rate comparable to control cells that were kept at pH 7.4 throughout the 3-day course of the experiment (see Supplementary material online, Figure S4 ).
Additional studies examined whether AP modulated ckit + cell adhesion to fibronectin and TNF-a-activated endothelium at pH 7.4. Interestingly, AP enhanced ckit + cell adhesion to both fibronectin-coated dishes (see Supplementary material online, Figure S5A ) and activated HUVEC monolayer (see Supplementary material online, Figure S5B ).
Effect of acidic preconditioning on CXCR4 and SDF-1 expression
Since CXCR4 signalling plays a pivotal role in precursor cell migration and homing, we examined whether AP modulates CXCR4 and SDF-1 expression. ckit + cells exposed to pH 7.0 exhibited a progressive increase in CXCR4 and SDF-1 mRNA levels; at the 5 h time point, neither the increase in CXCR4 nor in SDF-1 were statistically significant (data not shown), whereas at the 24 h time point CXCR4 and SDF-1 mRNA levels were 2.5 + 0.4 and 1.7 + 0.2 fold vs. control, respectively ( Figure 2A) . Interestingly, an increase in CXCR4 and SDF-1 mRNA was also observed in BM ckit + cells from ApoE 2/2 and diabetic mice (see Supplementary material online, Figure S6 ). Further, human BM ckit + cells exposed to AP exhibited a 1.3 + 0.2-fold increase in CXCR4 mRNA (n ¼ 5; P ¼ 0.03). The percentage of CXCR4 positive cells was determined by FACS analysis. At the 24 h time point, 50% control cells and 60% AP cells expressed CXCR4 with a mean fluorescence intensity of 20 and 24 for control and AP cells, respectively; both achieved statistical significance at the 48 h time point (see Supplementary material online, Figure S7A ). Further, we examined AP effect on CXCR4 phosphorylation; AP for 24 h enhanced CXCR4 phosphorylation, both under baseline conditions and upon exposure to SDF-1 (see Supplementary Figure 2B , upper panel). We next showed that NO played an important role in the upregulation of CXCR4 by acidosis. Nitric oxide donor DETA/NO enhanced CXCR4 expression in ckit + cells kept at normal pH, whereas NOS inhibitor L-NAME abolished AP-mediated CXCR4 increase ( Figure 2B , upper panel). In agreement with these results on NO and CXCR4 expression, ckit + cells kept at pH 7.0 for 6 h exhibited an increase in DAF positivity which was prevented by L-NAME ( Figure 2B , lower panel, and see Supplementary material online, Figure S8 ). As HIF-1a is a regulator of CXCR4 28, 29 and its expression is enhanced by acidification 20 and NO, 30 -32 we investigated whether AP effects on CXCR4 were paralleled by HIF-1a induction. To this end, we analysed HIF-1a expression in control cells following exposure to DETA/NO and in AP cells treated with L-NAME; both NO and acidification induced HIF-1a protein expression and L-NAME abolished this effect in AP cells (see Supplementary material online, Figure S9 ). Further, in control cells treated with L-NAME, there was a small decrease in HIF-1a expression, whereas in AP cells treated with DETA/NO there was an additional increase in HIF-1a expression (see Supplementary material online, Figure S9 ).
Effect of acidic preconditioning on SDF-1-directed ckit 1 cell migration and differentiation toward the endothelial lineage representative FACS analysis of DAF positivity; ckit + cells exposed to acidic preconditioning exhibited an increase in NO production which was prevented by L-NAME.
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was evaluated, both in chemotaxis and in transendothelial migration assays at pH 7.4. AP cells exhibited a higher ability than control cells to migrate in response to SDF-1 and this effect was abolished upon treatment with an anti-CXCR4 antibody ( Figure 3A) . SDF-1-directed transendothelial migration assays were performed under two different pH conditions. The endothelial monolayer was constituted by HUVECs that were grown for 16 h, prior to the assay, at either pH 7.4 or at pH 7.0 ( Figure 3B , upper and lower panel, respectively). Under both pH conditions, AP enhanced transendothelial migration. We then examined whether AP may modulate ckit + cell differentiation toward the endothelial lineage. To that end, ckit + cells were cultured for 24 h either at pH 7.4 or at pH 7.0 and then seeded onto fibronectin-coated dishes in the presence of 20% FCS for 7 days at pH 7.4. AP increased ckit + cell adhesion with over 95% adherent cells expressing endothelial cell markers (i.e. Factor VIII and KDR) and displaying Ac-DiI-LDL uptake ( Figure 4A-C ) . Additionally, we examined the role of SDF-1 in AP cell differentiation. To address this issue, culture medium was supplemented with 100 ng/mL SDF-1 and FCS concentration was lowered from 20 to 2%. SDF-1 markedly enhanced the number of DiI-Ac-LDL-positive cells following AP, whereas it had no effect on cells cultured at pH 7.4. This effect of SDF-1 on DiI-Ac-LDL uptake was abolished by an anti-CXCR4 blocking antibody ( Figure 4D ).
Effect of acidic preconditioning on ckit control cells at each time point analysed after cell injection ( Figure 5A ). Further, in adductor muscles injected with AP cells, we found a significant increase in capillary number ( Figure 5B ) and arteriole density ( Figure 5C ), an increase in regenerating muscle fibres 7 days after cell injection ( Figure 5D ) and a decrease in the area of tissue damage (see Supplementary material online, Figure S10 ). Conversely, no significant difference was found between mice treated with ckit + cells without exposure to AP vs. animals injected with saline. In light of the key role that NO plays in CXCR4 expression in response to AP, we next examined the therapeutic potential of ckit + cells exposed to AP and treated with L-NAME. These cells failed to enhance limb perfusion ( Figure 6A) , did not increase capillary number, had no effect on muscle regeneration ( Figure 6B and D) , and markedly inhibited the increase in arterioles ( Figure 6C) . When control cells were exposed to L-NAME, their behaviour was similar to that of untreated control cells; it was found only a delay in the perfusion index at the 7-day time point, and a marginal decrease in capillary number at Day 14, whereas there was no effect on arterioles, capillaries at Day 7 and on regenerating muscle fibres ( Figure 6) .
Discussion
The present study shows that AP increased CXCR4 expression in BM c-kit + cells. This effect was associated with enhanced SDF-1-directed cell migration and endothelial differentiation in vitro, and with a potentiated angiogenic and regenerative action in a mouse model of hindlimb ischaemia. Both in vitro and in vivo, AP effects were mediated by NO. Prior studies have examined the effect of acidification in a variety of cell types. It has been reported that a marked and prolonged decrease in pH has a negative effect on cell survival and function. 23, 33 In contrast, at least in endothelial cells, a brief exposure to a mild acidotic milieu exerts a beneficial action on survival and, upon returning to a normal pH, also on cell function. 33 These beneficial responses have been attributed to increased secretion of pro-survival angiogenic factors, i.e. fibroblast growth factor 2 and vascular endothelial growth factor, 23 and to enhanced expression of the tyrosine kinase receptor AXL; upon binding to its ligand, the survival factor growth arrest-specific gene 6 product (Gas6), AXL exerts an antiapoptotic action. 33 These in vitro studies are in agreement with in vivo results showing that preconditioning with brief episodes of acidosis limits ischaemia/ reperfusion injury in the heart, 14,15 lung, 16, 17 and endothelium. 18, 19 Our present work focused on CXCR4 because there is substantial evidence supporting SDF-1/CXCR4 key role in the response to cell therapy. In humans, impairment of CXCR4 signalling reduces the proangiogenic action of endothelial progenitor cells (EPC) 9 and the response to autologous BM cell transplantation into the ischaemic heart. 8 Another study has compared the functional activity of both CXCR4 + and CXCR4 2 human BM mononuclear cells and found that only CXCR4 + cells improved neovascularization in a murine model of hindlimb ischaemia. 8 Further, in a rodent model of myocardial infarction, hypoxic preconditioning augmented cardiac progenitor cell therapeutic efficacy by inducing CXCR4 expression. 12 We also found that ckit + cells exposed to AP also exhibited a marked increase in SDF-1 expression; this is expected to have a positive action via both autocrine and paracrine mechanisms. Indeed, cell priming with SDF-1 prior to transplantation enhances their therapeutic potential 34 ; further, direct SDF-1 injection into the ischaemic limb 35 and heart 36 induces a regenerative response and improves function. It is noteworthy Figure 6 L-NAME abolishes acidic preconditioning ability to enhance ckit + cell therapeutic potential in vivo. Treatment with L-NAME abolished acidic preconditioning cells ability to enhance limb perfusion (A), increase capillary number (B), and regenerating fibres at Day 7 (D); the increase in arterioles at Day 14 was markedly inhibited (C). Control cells, L-NAME treated and untreated, behaved similarly except for lower limb perfusion and capillary number in L-NAME-treated cells at Days 7 and 14, respectively (panel A, n ¼ 7 in each group; panels B -D, n ¼ 5 for each bar graph; *P , 0.05 L-NAME treated vs. untreated acidic preconditioning cells; I¨P , 0.05 for L-NAME-treated acidic preconditioning cells vs. control cells; # P , 0.05 for L-NAME-treated vs. untreated control cells).
that, in the present work, the increase in the CXCR4 protein induced by mild acidification for 24 h was relatively small. Nevertheless, AP for 24 h enhanced CXCR4 phosphorylation, both under baseline conditions and upon exposure to SDF-1. Further, a selective CXCR4 blocking antibody abolished both SDF-1-directed chemotaxis and differentiation toward the endothelial lineage. Taken together, these results link AP ability to modulate CXCR4 expression and activation, enhanced SDF-1 responsiveness in vitro, and improved therapeutic potential in vivo. The increase in CXCR4 expression in AP cells is expected to promote their migration toward ischaemic tissues which express high SDF-1 levels, 5 -7 and also facilitate CXCR4 + cell differentiation toward the endothelial lineage. Interestingly, AP enhanced CXCR4 expression also in BM ckit + cells from humans and from hypercholesterolemic and diabetic mice. Under our experimental conditions, NO is the key mediator linking acidification to CXCR4 expression. The NO donor DETA/NO mimicked AP ability to enhance CXCR4 expression; further, AP effects on CXCR4 expression and ckit + cells regenerative potential in vivo were abolished by the NOS inhibitor L-NAME. These results are in agreement with prior studies showing that a mild decrease in pH enhances NO production in vivo 37 and in vitro. 38 We have previously shown that acidification raises 25 which is a key event in triggering NO production. 26, 27 Accordingly, the intracellular Ca 2+ chelator BAPTA-AM prevented AP effect on CXCR4 expression. Further, CXCR4 expression is HIF-1a-dependent 28, 29 and, under our experimental conditions, HIF-1a increased both in response to DETA-NO 30 -32 and to AP; the latter effect was prevented by L-NAME. Therefore, both [Ca 2+ ] i and NO play a pivotal role in AP-mediated increase in CXCR4 expression. Interestingly, here we found that control ckit + cells, without AP exposure, failed to induce neovascularisation in vivo. It is noteworthy that the effect of EPC transplantation in animal models of hindlimb ischaemia is still controversial; most studies have shown an angiogenic response associated with an increase in blood flow, 5, 8, 35 whereas others have failed to show any beneficial response. 11, 39, 40 Further, numerous studies on this topic have utilized human cells obtained either from the peripheral circulation 8, 9, 35 or cord blood 34, 41 rather than BM cells, and have transplanted such cells in immunocompromised mice; in contrast, we have transplanted mouse BM cells in the ischaemic limb of same strain mice. Finally, no prior study has utilized an enriched population of BM ckit + cells for direct intramuscle injection in the mouse ischaemic hindlimb. These experimental differences may explain the discrepancy between our results with control cells and those prior studies which have shown a beneficial response to EPC transplantation in the mouse model of hindlimb ischaemia.
In conclusion, AP is a simple and unexpensive strategy to enhance BM ckit + cell therapeutic potential. Further, unlike other cell potentiating interventions, such as viral-mediated transfer of angiogenic or antiapoptotic genes, it is expected that regulatory agencies would readily accept AP as part of the cell preparation protocol for clinical use. Once BM cells have undergone the selection process under Good Manufacturing Practice (GMP) conditions, they would be placed in a hypercarbic environment to achieve a buffer pH of 7.0 for 24 h, prior to transplantation into the patient. 42 Therefore, AP represents a clinically applicable strategy to improve the therapeutic efficacy of BM cell transplantation.
Supplementary material
Supplementary material is available at European Heart Journal online.
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